Holen Sie sich die Stockscreener-App
131.84
0.53%
0.70
Handel nachbörslich:
131.84
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BIIB?
Forum
Prognose
Aktiensplit
Biogen Inc Aktie (BIIB) Neueste Nachrichten
Biogen to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - Biogen
Relapsing Remitting Multiple Sclerosis Market Set to Witness - openPR.com
Ex-Biogen Chief Medical Officer Strengthens Entrada's Duchenne Program as Phase 1 Data Shows Promise - Stock Titan
Neuromuscular Disease Therapeutics Market Growth Driven - openPR.com
152,867 Shares in Biogen Inc. (NASDAQ:BIIB) Acquired by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat
First County Bank CT Makes New Investment in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Lansforsakringar Fondforvaltning AB publ Makes New Investment in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
City Therapeutics Partners with Biogen - Global Legal Chronicle
Biogen Inc. stock outperforms competitors on strong trading day - MarketWatch
Biogen Inc. (NASDAQ:BIIB) Holdings Raised by Centre Asset Management LLC - MarketBeat
California State Teachers Retirement System Buys 2,811 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen Inc. (NASDAQ:BIIB) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Toronto Dominion Bank Has $11.11 Million Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Mackenzie Financial Corp Purchases 19,759 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Farmers Trust Co. Acquires 2,012 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
William Blair Brokers Lower Earnings Estimates for Biogen - MarketBeat
Lighthouse Financial LLC Makes New Investment in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen Inc (BIIB)'s Uncertain Future: Understanding the Barriers to Outperformance - GuruFocus
Auxier Asset Management Sells 2,136 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Q1 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks - Yahoo Finance
GF Fund Management CO. LTD. Makes New $5.24 Million Investment in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Progressive Supranuclear Palsy Treatment Market Set to Witness GrowthBiogen, AbbVie - openPR.com
PKO Investment Management Joint Stock Co Takes Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen and City Therapeutics partner to develop RNAi therapies - MSN
Biogen Inc. (NASDAQ:BIIB) Shares Sold by USS Investment Management Ltd - MarketBeat
Siemens Fonds Invest GmbH Grows Stock Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Public Employees Retirement System of Ohio Sells 2,866 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Voloridge Investment Management LLC Invests $23.20 Million in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $234.55 Million Stock Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Tauopathies Treatment Market Detailed in New Research ReportBiogen, AbbVie - openPR.com
Amyotrophic lateral Sclerosis Market 2025-2032: Top Trends & - openPR.com
Recombinant Dna Technology Market Generated Opportunities, - openPR.com
In Vitro Monoclonal Antibodies Market is expected to reach US$ - openPR.com
Biogen and City Therapeutics to develop RNAi therapy - Yahoo Finance
Biogen and City Therapeutics partner to advance RNAi therapies - World Pharmaceutical Frontiers
Biogen Inc. (NASDAQ:BIIB) Holdings Lifted by Quantinno Capital Management LP - MarketBeat
Woodline Partners LP Boosts Stock Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen’s SWOT analysis: stock faces challenges amid neuroscience potential - Investing.com
Biogen’s SWOT analysis: stock faces challenges amid neuroscience potential By Investing.com - Investing.com UK
Biogen Inc. (BIIB) Taps RNAi Therapy in City Therapeutics Deal - Yahoo Finance
Biogen (NasdaqGS:BIIB) Partners With City Therapeutics in US$1 Billion RNAi Therapy Deal - simplywall.st
Biogen partners with John Maraganore’s new RNAi startup - The Business Journals
Biogen (BIIB) Partners with City Therapeutics for RNAi Therapies - GuruFocus
Biogen strikes RNAi deal with City; Aurion withdraws IPO - BioPharma Dive
City hits the town with $1B-plus deal with Biogen - BioWorld MedTech
Biogen and City Therapeutics collaborate on RNAi meds - The Pharma Letter
Biogen taps City Therapeutics in RNAi deal worth up to $1B - Endpoints News
Biogen (BIIB) Collaborates with City Therapeutics on RNAi Therap - GuruFocus
Biogen and City Therapeutics Announce Strategic Research Collabo - GuruFocus
0.47%
0.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):